Generalized dermatophytosis and tinea capitis mimicking psoriasis in a patient with long‐term infliximab treatment
Inmaculada Balaguer‐Franch, Elisa Hernández de la Torre‐Ruiz, Ofelia Baniandrés
Clinical and Experimental Dermatology · 2021-01
Abstract
Anti-tumour necrosis factor (TNF)-a monoclonal antibody therapies are approved for treatment of chronic diseases, with an increased risk of opportunistic infections like tuberculosis or invasive fungal infections. On the other hand, paradoxical cutaneous effects, such as psoriasiform dermatitis, have been described with them.
MeSH terms
- Medicine
- Tinea capitis
- Psoriasis
- Infliximab
- Dermatology
- Tuberculosis
- Monoclonal antibody
- Immunology
- Tumor necrosis factor alpha